FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Checking PSA levels too soon after prostate cancer surgery can lead to overtreatment, study suggests

2.

Six breast texture patterns linked to higher risk of invasive cancer

3.

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

4.

For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

5.

Firefighters who eat better can combat cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot